View in EDS HTML Full Text PDF Full Text

Camrelizumab Plus Famitinib in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Phase 2 Study.

Saved in:
Bibliographic Details
Title: Camrelizumab Plus Famitinib in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Phase 2 Study.
Authors: Xu, Bei1 (AUTHOR), Zhu, Guopei2 (AUTHOR), Lu, Jin3 (AUTHOR), Zhang, Ximei4 (AUTHOR), Chen, Xiaozhong5 (AUTHOR), Liu, Qinjiang6 (AUTHOR), Qu, Song7 (AUTHOR), Fan, Jia8 (AUTHOR) fan.jia@zs‐hospital.sh.cn, Liu, Tianshu1 (AUTHOR) liu.tianshu@zs‐hospital.sh.cn
Source: Cancer Medicine. May2026, Vol. 15 Issue 5, p1-12. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20457634
DOI:10.1002/cam4.71899